BollackC., OliveuxA., MethlinG., VanegasM.: Notre experience de la scintigraphic osseuse aux pyrophosphates technétiés dans le bilan d'extension du cancer de la prostate. J. d'Urol., 82; 885–893 (1976).
2.
BrianC. Lentle, DavidG. Mcgowan, HelgaDierich: 99mTc polyphosphate bone scanning in carcinoma of the prostate. Brit. J. Urol., 46; 543–548 (1974).
3.
PaulsonD. F.: Assessment of anatomic extent and biologic hazard of prostatic adenocarcinoma. Urology., 15; 537–541 (1980).
4.
DurvalA., PonchiettiR., PiccoloA.: La scintigrafia con tecnezio pirofosfato (99mTc-P. P.) nell'orientamento terapeutico del carcinoma prostatico. Giornate it. Urol., 597–599 (1975).
5.
HardyJ. G., KulatilakeA. E., WastieM. L.: An index for monitoring bone metastases from carcinoma of the prostate. Brit. J. Radiol., 53; 869–875 (1980).
6.
MantovaniP., CianciG., BianchiF.: Diagnosi precoce scintigrafica delle metastasi ossee da carcinoma prostatico con tecnezio 99. Comunicaz. tenuta al 50° Congr. Soc. it. Urol., p. 117–124, Ancona 1977.
7.
OliveuxA., GrobJ. C., MoysesB., MethlinG., BollackC.: Mise au point sur les explorations isotopiques du squelette dans les cancers de la prostate. Ann. d'Urol., 13; 167–171 (1979).
8.
SartoniGalloni S., MalagolaC., TarozziC.: La scintigrafia ossea MDP (metilendifosfonato) marcato con 99mTc e l'indagine radiograflca nello studio delle metastasi scheletriche. Ann. radiol. Diagn., 46; 469–475 (1978).
9.
SubramanianC., McAffeJ. G.: A new complex of 99mTc for skeletal imaging. Radiology, 99; 192 (1971).
10.
SubramanianG., BlairR. J., KallfelzE. A.: 99mTc-MDP (metylene diphosphonate): A superior agent for skeletal imaging. J. nucl. Med., 14; 640 (1973).
11.
SubramanianG., McAffeJ. G., BlairR. J.: Technetium 99m-metylene diphosphonate a superior agent for skeletal imaging: comparisons with other technetium complexes. J. nucl. Med., 16; 744 (1975).
12.
RuddT. G., AllenD. R., HartnettD. E.: 99mTc methylene diphosphonate versus 99mTc pyrophosphate: biologic and clinical comparison. J. nucl. Med., 18; 872–876 (1977).
